1. Analysis of racial variations in disease characteristics, treatment patterns, and outcomes of patients with chronic lymphocytic leukemia. Issue 7 (24th April 2016) Authors: Nabhan, Chadi; Chaffee, Kari G.; Slager, Susan L.; Galanina, Natalie; Achenbach, Sara J.; Schwager, Susan M.; Kay, Neil E.; Shanafelt, Tait D. Journal: American journal of hematology Issue: Volume 91:Issue 7(2016:Jul.) Page Start: 677 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Emerging role of checkpoint blockade therapy in lymphoma. (February 2017) Authors: Galanina, Natalie; Kline, Justin; Bishop, Michael R. Journal: Therapeutic advances in hematology Issue: Volume 8:Number 2(2017) Page Start: 81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Frequency, risk factors, and outcomes of central nervous system relapse in lymphoma patients treated with dose‐adjusted EPOCH plus rituximab. Issue 11 (17th August 2017) Authors: Malecek, Mary‐Kate; Petrich, Adam M.; Rozell, Shaina; Chu, Benjamin; Trifilio, Steven; Galanina, Natalie; Maurer, Matthew; Farooq, Umar; Link, Brian K.; Nowakowski, Grzegorz S.; Nabhan, Chadi; Ayed, Ayed O. Journal: American journal of hematology Issue: Volume 92:Issue 11(2017:Nov.) Page Start: 1156 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Ofatumumab monotherapy in relapsed/refractory diffuse large B-cell non-Hodgkin lymphoma. Issue 3 (4th March 2017) Authors: Galanina, Natalie; Jasielec, Jagoda; Peace, David; Smith, Sonali M.; Nabhan, Chadi Journal: Leukemia & lymphoma Issue: Volume 58:Issue 3(2017) Page Start: 752 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Remembering the forgotten child: the role of immune checkpoint inhibition in patients with human immunod eficiency virus and cancer. Issue 1 (22nd May 2019) Authors: Adashek, Jacob J.; Junior, Pedro Nazareth Aguiar; Galanina, Natalie; Kurzrock, Razelle Journal: Journal for immunotherapy of cancer Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Successful implementation of genomically based treatment of chemotherapy refractory peripheral T-cell lymphoma (PTCL). Issue 3 (4th March 2019) Authors: Galanina, Natalie; Kurzrock, Razelle Journal: Cancer biology & therapy Issue: Volume 20:Issue 3(2019) Page Start: 247 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The evolving role of lenalidomide in non-Hodgkin lymphoma. Issue 7 (2nd July 2016) Authors: Galanina, Natalie; Petrich, Adam; Nabhan, Chadi Journal: Leukemia & lymphoma Issue: Volume 57:Issue 7(2016:Jul.) Page Start: 1507 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. University of Chicago phase II consortium trial of selumetinib (MEKi) demonstrates low tolerability and efficacy in relapsed DLBCL. (17th April 2017) Authors: Galanina, Natalie; Smith, Sonali M.; Liao, Chuanhong; Petrich, Adam; Libao, Bernadette; Gartenhaus, Ronald; Westin, Jason R.; Cohen, Kenneth S.; Knost, James A.; Stadler, Walter M.; Doyle, Austin; Karrison, Theodore; Gordon, Leo I.; Evens, Andrew M. Journal: British journal of haematology Issue: Volume 181:Number 2(2018) Page Start: 264 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗